The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Creatine uptake regulates CD8 T cell antitumor immunity
Open accessAbstract
T cells demand massive energy to combat cancer; however, the metabolic regulators controlling antitumor T cell immunity have just begun to be unveiled. When studying nutrient usage of tumor-infiltrating immune cells in mice, we detected a sharp increase of the expression of a CrT (Slc6a8) gene, which encodes a surface transporter controlling the uptake of creatine into a cell. Using CrT knockout mice, we showed that creatine uptake deficiency severely impaired antitumor T cell immunity. Supplementing creatine to WT mice significantly suppressed tumor growth in multiple mouse tumor models, and the combination of creatine supplementation with a PD-1/PD-L1 blockade treatment showed synergistic tumor suppression efficacy. We further demonstrated that creatine acts as a “molecular battery” conserving bioenergy to power T cell activities. Therefore, our results have identified creatine as an important metabolic regulator controlling antitumor T cell immunity, underscoring the potential of creatine supplementation to improve T cell–based cancer immunotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“reduce the progress of some forms of cancer [8,17,18,135,144,145,146,147];”
From Creatine in health and disease (2021) · cites this paper as [17]
In the citing paper
“Additionally, the creatine transport SLC6A8 gene expression encodes a surface transporter controlling the uptake of creatine into a cell, markedly increases in tumor-infiltrating immune cells [17].”
From Creatine in health and disease (2021) · cites this paper as [17]
In the citing paper
“Prior studies have shown that creatine content and energy availability are low in several types of malignant cells and T cells that mediate the immune responses against cancer [17,18,144,145,147].”
From Creatine in health and disease (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652 · cited 1×
“In particular, the PD-1hiTim3hiLAG-3hi tumor-infiltrating CD8 T cells, which are considered to be the most “exhausted,” expressed the highest levels of CrT, suggesting that these cells may also benefit the most from creatine supplementation treatment (Fig. S1 K; Nguyen and Ohashi, 2015; Wherry and Kurachi, 2015).”
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 8×
“Expression of CrT is important for cells demanding high energy, such as muscle cells and brain cells; in humans, CrT deficiency has been associated with muscle diseases and neurological disorders (Wyss and Kaddurah-Daouk, 2000).”
InfluentialAdoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051 · cited 2×
“T cells play a central role in mediating and orchestrating immune responses against cancer; therefore, they are attractive therapeutic targets for treating cancer (Couzin-Frankel, 2013; Page et al., 2014; Ribas, 2015; Rosenberg and Restifo, 2015; Baumeister et al., 2016; Lim and June, 2017).”
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974
The Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080 · cited 2×
“Mouse tumor models B16-OVA murine melanoma cells (obtained from the laboratory of Pin Wang, University of Southern California, Los Angeles, CA; Liu et al., 2014) and MC38 murine colon adenocarcinoma cells (obtained from the laboratory of Antoni Ribas, UCLA, Los Angeles, CA; Homet Moreno et al., 2016) were cultured in…”
InfluentialKreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057 · cited 1×
“…some early studies showed that creatine and creatine analogues could directly inhibit cancer growth, presumably through disrupting cancer cell metabolism, suggesting an additional mechanism that creatine may employ to mediate its antitumor effects (Miller et al., 1993; Kristensen et al., 1999).”
Coinhibitory Pathways in Immunotherapy for Cancer
Baumeister, S. H., Freeman, G. J., Dranoff, G., & Sharpe, A. H. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112049 · Cited by 910
Bengsch, B., Johnson, A. L., Kurachi, M., Odorizzi, P. M., Pauken, K. E., Attanasio, J., Stelekati, E., McLane, L. M., Paley, M. A., Delgoffe, G. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.008 · Cited by 868 · cited 2×
“…blockade therapies, have been indicated to correct the glucose usage imbalance between tumor cells and T cells by altering glycolysis and directing the energy metabolism to favor T cells (Gubin et al., 2014; Chang et al., 2015; Baumeister et al., 2016; Bengsch et al., 2016; Scharping et al., 2016).”
BackgroundInfluentialFuel feeds function: energy metabolism and the T-cell response
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1710 · Cited by 853
Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.009 · Cited by 848
Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.009 · Cited by 706
Clinical blockade of PD1 and LAG3 — potential mechanisms of action
Nguyen, L. T., & Ohashi, P. S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3790 · Cited by 627 · cited 2×
“In particular, the PD-1hiTim3hiLAG-3hi tumor-infiltrating CD8 T cells, which are considered to be the most “exhausted,” expressed the highest levels of CrT, suggesting that these cells may also benefit the most from creatine supplementation treatment (Fig. S1 K; Nguyen and Ohashi, 2015; Wherry and Kurachi, 2015).”
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Kishton, R. J., Sukumar, M., & Restifo, N. P. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.016 · Cited by 548
Immune Modulation in Cancer with Antibodies
Page, D. B., Postow, M. A., Callahan, M. K., Allison, J. P., & Wolchok, J. D. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-092012-112807 · Cited by 515 · cited 1×
“7 D; Pardoll, 2012; Couzin-Frankel, 2013; Page et al., 2014; Ribas, 2015; Rosenberg and Restifo, 2015; Baumeister et al., 2016; Lim and June, 2017).”
Emerging concepts of T cell metabolism as a target of immunotherapy
Chang, C.-H., & Pearce, E. L. (2016) · Nature Immunology · doi:10.1038/ni.3415 · Cited by 338
Tamás, P., Hawley, S. A., Clarke, R. G., Mustard, K. J., Green, K., Hardie, D. G., & Cantrell, D. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052469 · Cited by 328 · cited 1×
“It serves as a nutrient and energy sensor to maintain cell energy homeostasis and has been indicated to regulate T cell metabolism and function (Tam´as et al., 2006; Hardie et al., 2012; Rao et al., 2016; Ma et al., 2017).”
T cell metabolic fitness in antitumor immunity
Siska, P. J., & Rathmell, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.007 · Cited by 312 · cited 1×
“Therefore, an efficient and economical bioenergy metabolism is needed for tumor-infiltrating T cells to mount and sustain effective anticancer responses (Siska and Rathmell, 2015).”
Releasing the Brakes on Cancer Immunotherapy
Ribas, A. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1510079 · Cited by 252 · cited 2×
“T cells play a central role in mediating and orchestrating immune responses against cancer; therefore, they are attractive therapeutic targets for treating cancer (Couzin-Frankel, 2013; Page et al., 2014; Ribas, 2015; Rosenberg and Restifo, 2015; Baumeister et al., 2016; Lim and June, 2017).”
mTOR signaling in the differentiation and function of regulatory and effector T cells
Zeng, H., & Chi, H. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.005 · Cited by 198
The role of AMPK in T cell metabolism and function
Ma, E. H., Poffenberger, M. C., Wong, A., & Jones, R. G. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.004 · Cited by 164
Moreno, B. H., Zaretsky, J. M., García-Díaz, Á., Tsoi, J., Parisi, G., Robert, L., Meeth, K. M., Ndoye, A., Bosenberg, M., Weeraratna, A. T., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0060 · Cited by 160 · cited 3×
“…CA; Liu et al., 2014) and MC38 murine colon adenocarcinoma cells (obtained from the laboratory of Antoni Ribas, UCLA, Los Angeles, CA; Homet Moreno et al., 2016) were cultured in high-glucose (4.5 g/liter) DMEM supplemented with 10% FBS and penicillin-streptomycin (Thermo Fisher…”
InfluentialmiR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity
Li, B., Wang, X., Choi, I. Y., Wang, Y.-C., Liu, S., Pham, A. T., Moon, H., Smith, D. J., Rao, D. S., Boldin, M. P., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94012 · Cited by 132
Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency
Skelton, M. R., Schaefer, T. L., Graham, D. L., deGrauw, T. J., Clark, J. F., Williams, M. T., & Vorhees, C. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016187 · Cited by 123 · cited 6×
“CrT-KO mice show impeded control of tumor growth To address this question, we began by studying CrT-KO mice (Fig. S1 A; Skelton et al., 2011).”
InfluentialTargeting T cell metabolism to regulate T cell activation, differentiation and function in disease
Patel, C. H., & Powell, J. D. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.006 · Cited by 120 · cited 1×
“It serves as a nutrient and energy sensor to maintain cell energy homeostasis and has been indicated to regulate T cell metabolism and function (Tam´as et al., 2006; Hardie et al., 2012; Rao et al., 2016; Ma et al., 2017).”
Liu, Y., Liang, X., Joo, K., Hu, B., Fang, J., & Wang, P. (2014) · Biomacromolecules · doi:10.1021/bm501166j · Cited by 103
Beyond muscles: The untapped potential of creatine
Riesberg, L. A., Weed, S. A., McDonald, T. L., Eckerson, J. M., & Drescher, K. M. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2015.12.034 · Cited by 95 · cited 2×
“Conversely, CrT has been suggested as a possible biomarker for circulating tumor cells within the blood, posing the concern that creatine supplement may have potential negative effects on CrT-positive tumors (Riesberg et al., 2016).”
Inhibition of rate of tumor growth by creatine and cyclocreatine
Miller, E. E., Evans, A. E., & Cohn, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3304 · Cited by 82 · cited 1×
“S1 K; Nguyen and Ohashi, 2015; Wherry and Kurachi, 2015).”
Reenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries
Ho, P., & Kaech, S. M. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.003 · Cited by 64
Kristensen, C. A., Askenasy, N., Jain, R. K., & Koretsky, A. P. (1998) · British Journal of Cancer · doi:10.1038/sj.bjc.6690045 · Cited by 54
AMPK-dependent and independent effects of AICAR and compound C on T-cell responses
Rao, E., Zhang, Y., Li, Q., Hao, J., Egilmez, N. K., Suttles, J., & Li, B. (2016) · Oncotarget · doi:10.18632/oncotarget.9277 · Cited by 50 · cited 2×
“T cells play a central role in mediating and orchestrating immune responses against cancer; therefore, they are attractive therapeutic targets for treating cancer (Couzin-Frankel, 2013; Page et al., 2014; Ribas, 2015; Rosenberg and Restifo, 2015; Baumeister et al., 2016; Lim and June, 2017).”
An overview of amines as nutritional supplements to counteract cancer cachexia
de Campos‐Ferraz, P. L., de Andrade, I. T., das Neves, W., Hangai, I., Alves, C. R. R., & Lancha, A. H. (2014) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-014-0138-x · Cited by 47
Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells
Smith, D. J., Liu, S. J., Ji, S., Li, B., McLaughlin, J., Cheng, D., Witte, O. N., & Yang, L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424877112 · Cited by 43 · cited 2×
“Retroviruses were produced using HEK293T cells following a standard calcium precipitation method (Smith et al., 2015; Li et al., 2017).”
Reviewing the impact of lipid synthetic flux on Th17 function
Kidani, Y., & Bensinger, S. J. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.03.012 · Cited by 24
SMAD family member 3 (SMAD3) and SMAD4 repress HIF2α-dependent iron-regulatory genes
Ma, X., Das, N. K., Castillo, C., Gourani, A., Perekatt, A. O., Verzi, M. P., & Shah, Y. M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005549 · Cited by 21
Metabolic reprogramming of the immune response in the tumor microenvironment
McCarthy, S. A., Mufson, R. A., Pearce, E. J., Rathmell, J. C., & Howcroft, T. K. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23616 · Cited by 15 · cited 1×
“…some early studies showed that creatine and creatine analogues could directly inhibit cancer growth, presumably through disrupting cancer cell metabolism, suggesting an additional mechanism that creatine may employ to mediate its antitumor effects (Miller et al., 1993; Kristensen et al., 1999).”
Cited by
Regulatory mechanisms of PD-1/PD-L1 in cancers
Lin, X., Kang, K., Chen, P., Zeng, Z., Li, G., Xiong, W., Yi, M., & Xiang, B. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02023-w · Cited by 784
CD8+ T cell metabolism in infection and cancer
Reina-Campos, M., Scharping, N. E., & Goldrath, A. W. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00537-8 · Cited by 612
Arginine-dependent immune responses
Martí i Líndez, A.-A., & Reith, W. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03828-4 · Cited by 354
“Tumor-infiltrating T cells express low levels of creatine-synthesizing enzymes AGAT and GAMT and primarily rely on creatine uptake via increased expression of its plasma membrane transporter SLC6A8 [250].”
BackgroundInfluentialCreatine metabolism: energy homeostasis, immunity and cancer biology
Kazak, L., & Cohen, P. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0365-5 · Cited by 265
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
“Prior studies have shown that creatine content and energy availability are low in several types of malignant cells and T cells that mediate the immune responses against cancer [17,18,144,145,147].”
BackgroundInfluential
Metadata
- Authors
- Di Biase, S., Ma, X., Wang, X., Yu, J., Wang, Y.-C., Smith, D. J., Zhou, Y., Li, Z., Kim, Y. J., Clarke, N., To, A., & Yang, L.
- Affiliations
- Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 1
- University of California, Los Angeles (US)
- Corresponding author
- Yang, Lili
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2019-10-18
- Volume
- 216
- Issue
- 12
- Pages
- 2869-2882
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC6888972
- OpenAlex
- W2980348324
- Cited by
- 132
- References
- 40
- Citations by year
- 2026: 22 · 2025: 24 · 2024: 21 · 2023: 13 · 2022: 16 · 2021: 31 · 2020: 5
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- UCLA
- National Institutes of Health (DP2 CA196335)
- US Department of Health and Human Services (T32 CA009056)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- creatine uptake, SLC6A8, CD8+ T cells, antitumor immunity, T cell metabolism, creatine supplementation, PD-1/PD-L1 blockade, tumor-infiltrating immune cells, cancer immunotherapy
- MeSH terms
- Animals, Antigens, Neoplasm, Creatine, Energy Metabolism, Humans, Lymphocyte Activation, Models, Biological, Neoplasms, Gene Expression Regulation, Neoplastic, Mice, Knockout, CD8-Positive T-Lymphocytes, Dietary Supplements, Membrane Transport Proteins, Cell Line, Tumor, Mice, Immunomodulation, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.